PFE vs RYAN · P/E 20, rev $62.58B vs P/E 43, rev $2.46B
Pfizer Inc (PFE) versus Ryan Specialty Group Holdings Inc (RYAN) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Ryan Specialty Group Holdings Inc (RYAN) is a insurance - specialty company listed on NYSE.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported RYAN revenue for 2024-12-31 was $2.46B. Net income was $229.9M. Revenue was up 21.2% from 2023-12-31 to 2024-12-31. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
Not investment advice. Open the PFE and RYAN stock pages for the full models.
Not investment advice.